Recognition and management of toxoplasmosis

Nurse Practitioner

Volumn 22, Issue 9, 1997, Pages 75-89

  Heitman, Brenda B ^a   Irizarry, Andres F ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b FLORIDA INTERNATIONAL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AIDS RELATED COMPLEX; CASE REPORT; CONGENITAL TOXOPLASMOSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; IMMUNE DEFICIENCY; MALE; NEWBORN; PARASITOLOGY; PREGNANCY; REVIEW; TOXOPLASMOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOCOMPROMISED HOST; INFANT, NEWBORN; MALE; PREGNANCY; TOXOPLASMOSIS; TOXOPLASMOSIS, CONGENITAL;

EID: 0031225662     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1080/00006205-199709000-00006     Document Type: Article

References (37)

1. Dcckcr CF, Masur H: Infectious complications, pneumocystis ancl other protozoa. In: Devita, V, Heilman, S, & Rosenberg, S, eds. AIDS, Etiology, Diagnosis, Treatment and Prevention. 4th. ed. Philadelphia: J.B. Lippincott, 1997:221-25.
2. Wong SY, Israclski DM, Remington JS: AIDS-associated toxoplasmosis. In: Sande, MA, Volberding, PA, eds. The Medical Management of AIDS. 4th Ed. Philadelphia: W.B. Saunders, 1995:460-83.
3. Sun T: Current topics in protozoal diseases. Clin Microbio and Inf Dis. 1994;102:16-29.
4. Beaman MM, McCabe RE, Wong S, et al: In: Mandell GL, Bennett: JE, & Dolin R, eds. Principles and Practices of Infectious Diseases. 4th. ed. New York: Churchill Livingstone, 1995:2455-2470.
5. Subauste CS, Remington JS: Toxoplasmosis. In: Bennett, JC, Plum, F, eds. Cecil’s Textbook of Medicine. 20th. ed. Philadelphia: W.B. Saunders, 1996:1907-10.
6. Gellin BG, Soave R: Coccidian infections in AIDS. The Med Clin of N Amer. 1992;76(1); 205-16.
7. Richards RO, Kovacs JA, Luft BJ: Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Inf Dis. 1995;21 (Suppl 1):S49-56.
8. Luft BJ, Remington JS: Toxoplasmosis. In: Hoeprich P, Jordan MC, Ronald A, eds. Infectious Disease A Treatise of Infectious Processes. Philadelphia: J.B. Lippincott Co., 1994:1201-13.
9. Mariuz P, Bosler E, Luft BJ: Toxoplasmosis in individuals with AIDS. Inf Dis Clin of N Am. 1994; 8 (2):365-75.
10. Wong S, Remington J: Toxoplasmosis in AIDS. In: Phair, JP. ed. Opportunistic Complications of HIV. 1993;2(3): 44-56.
11. Cohen PT, Sande MA, Volberding PA, et al: The AIDS Knowledge Base. 2nd ed. California: Un. Of California, 1994: 6.1922-1926.
12. Wong S, Remington JS: Toxoplasmosis in the setting of AIDS. In: Brodcr S, T, & Bolognesi D, eds. Textbook of AIDS Medicinc. Philadelphia: Williams & Wilkins; 1994:223-57.
13. Wong SY, Remington JS: The biology ofToxolasma gondii. AIDS. 1993:7299-317.
14. Schnapp L, Geaghan S, Campagna A, et al: Toxoplasma gondii pneumonitis in patients infected with the human immunodeficiency syndrome. Arch Intern Med. 1992;152:1073-76.
15. Cochereau-Massin I, Lcl-Ioang P, Lauticr-Frau M, et al: Ocular toxoplasmosis in human immunodeficiency virus-infected patients. Am J Ophthalmol. 1992;114:130-35.
16. Wong SY, Israclski D, Remington J: AIDS-Associated toxoplasmosis. In Sande, M & Volberding, eds. The Medical Management of AIDS. 3rd. Ed. Philadelphia: W.B. Saunders Co. 1995:460-82.
17. Bakh, FR, Gentry LO: Toxoplasmosis is pregnancy: an emerging concern for family physicians. Am Fain Phys. 1992;45(4): 1683-90.
18. Simpson DM: Neurologic manifestations of HIV disease. Improving The Management of HIV Disease. 1995;3(4): 12-17.
19. Newton I-IB: Common neurologic complications of HIV-1 infection and AIDS. Am Fain Phys. 1995;51(2):387-98.
20. Zuger A, Louie E, I-Iolzman R: Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Diagnostic features and outcome of treatment. Ann Intern Med. 1986;104:234-40.
21. Price W, Brew BJ: Central and peripheral nervous system complications. In Devita JR, Heilman S. & Rosenberg eds. AIDS, Etiology, Diagnosis, Treatment & Prevention. 4th. ed. Philadelphia: J.B. Lippincott Company. 1997: 331-343.
22. Simpson DM, Tagaliati M: Neurologic manifestations of MTV infection. Ann Intern Med. 1994;121:769-85.
23. Peiperl L: Manual of HIV/AIDS Therapy. 2nd. ed. Los Angeles: Current Clinical Strategics Publishing, 1995.
24. Danncmann B, McCutchan JA, Israclski D et al: Treatment of toxoplasmic encephalitis in patients with AIDS. A randomized trial comparing pyrimethamine plus clindamycin to pyrimethamine plus Sulfadiazine. Ann Intern Med. 1992;1 16:33-43.
25. Berger JR, Levy RM: The neurologic complications of human immunodeficiency virus infection. Med Clin North Am. 1993;7(1) 1-9.
26. Porte SB, Sande MA: Toxoplasmosis of the central nervous system in the Acquired Immunodeficiency Syndrome. N Engl J Med. 1992;327:1643-48.
27. Iacoangclia M, Roselli R, Antinori A, et al: Experience with brain biopsy in acquired immune deficiency syndrome-related focal lesions of the central nervous system. Brit J of Surg. 1994; 181(10) 508-11.
28. American Foundation for AIDS Research. AIDS/HIV Treatment Directory, Special edition for XI International conference on AIDS. Vol. 8, No. 2, June 1996:119-23.
29. Gallant JE, Moore RD, Chaisson JE: Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 1994; 120(11):932-44.
30. Girald PM, Landman R, Gaudebout C, et al: Dapsonc-pyrimcthamine compared with aerosolized pentamidine as primary prophylaxis against Pneumocystis carinii pneumonia and toxoplasmosis in HIV infection. N Engl J Med. 1993;328:1514-20.
31. Podzamcczer D, Salazar A, Jimenez J. et al: Intermittent trimethoprim-sul-famethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV. Ann Intern Med. 1995;122:755-61.
32. Tierney LM, McPhec SJ, Papadakis MA: Current Medical Diagnosis and Treatment. Stanford: Appleton & Lange, 1996:1140-42.
33. CDC. Guidelines for the prevention of opportunistisc infections in persons infected with Human Immunodeficiency Virus: A summary. 1995;44(no. RR-8)5-26.
34. Bartlett J: The Johns Hopkins Hospital Guide to Medical Care of Patients with I-IR7 Infection. 5th. ed. Baltimore: The Johns Hopkins University School of Medicine. 1995;50-73.
35. Katlama C, Mouthon B, et al: Atovaquonc as long-term suppressive therapy for toxoplasmic encephaliltis in patients with AIDS and multiple drug intolerance. AIDS. 1996; 10:1107-12.
36. Wallace MR, Rossetti R, Olson P: Cats and toxoplasmosis risk in I-IIV-infected adults. J Am Med Assoc. 1993;269(1)76-77.
37. Centers for Disease Control. Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993;42(No. RR-17).